Commentary · 2016
EditorialPublished 27 Oct 2021
Surveillance For Prostate Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Prostate malignant growth is the most widely recognized disease in men in the United Realm (UK), with more than 42,000 men being determined to have the condition each year. It is the second most normal malignant growth in men around the world. More than 1.1 million instances of prostate disease were analyzed in 2012. Нe utilization of 3rostDte-6 Antigen (PSA) testing has prompted a general expansion in the frequency of prostate malignant growth rates. Its utilization has likewise brought about the early location of a huge number of limited prostate disease cases, which don't represent a danger to patients' wellbeing or lives.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 27 Mar 2023
Treatment Options for Prostate Cancer: From Active Surveillance to Surgery
Opinion · 28 Nov 2023
Surgical Innovations in Prostate Cancer: Enhancing Precision and Minimizing Impact
Conference abstract · 4 Apr 2022
CYP19A1 is regulated by BRD4 and suppresses castration-resistant prostate cancer cell invasion and proliferation by decreasing AR expression
Conference abstract · 4 Apr 2022
NPM1 promotes the progression of castration-resistant prostate cancer through a c-Myc-mediated pathway via BRD4
More from this journal
The newest in Journal of Cancer Clinical Trials.
Article · 26 Oct 2026
Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience
Article · 3 Jul 2026
The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyrimidine Monotherapy to Oxaliplatin-Based Regimens
Brief report · 29 Dec 2025
Validating Cancer Biomarkers: Challenges and Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cancer Clinical Trials
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Thomas Mehar”

